We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
+16.75%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$2.45B
AUM Growth
+$190M
Cap. Flow
-$50.3M
Cap. Flow %
-2.05%
Top 10 Hldgs %
18.35%
Holding
310
New
106
Increased
57
Reduced
61
Closed
23

Sector Composition

Rank Sector Weight
1 Healthcare 20.08%
2 Financials 17.24%
3 Consumer Discretionary 15.54%
4 Industrials 14.09%
5 Technology 12.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IIN
301
DELISTED
IntriCon Corporation
IIN
-167,531
Closed -$3.26M
ARNA
302
DELISTED
Arena Pharmaceuticals Inc
ARNA
-281,577
Closed -$12.9M
LVGO
303
DELISTED
Livongo Health, Inc. Common Stock
LVGO
-74,110
Closed -$1.29M
ARQL
304
DELISTED
Arqule Inc
ARQL
-1,380,009
Closed -$9.89M

Similar funds

Emerald Mutual Fund Advisers Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Emerald Mutual Fund Advisers Trust held 310 positions worth $2.45B, up 8.4% from $2.26B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q4 2019 filing shows 106 new, 57 increased, 61 reduced and 23 closed positions. Its largest new stake was BellRing Brands: 1,572,144 shares worth $33.5M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $30.9M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emerald Mutual Fund Advisers Trust's largest Q4 2019 buy was BellRing Brands: 1,572,144 shares worth $33.5M.
  • Emerald Mutual Fund Advisers Trust added most to Perficient Inc in Q4 2019, an estimated $14.6M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $30.9M.
  • Emerald Mutual Fund Advisers Trust fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $12.9M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 18% of its $2.45B portfolio in Q4 2019.
  • Emerald Mutual Fund Advisers Trust opened 106 new positions and closed 23 in Q4 2019.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 8.4% quarter-over-quarter to $2.45B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2019, filed 29 Jan 2020.